• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Prostate and testis expressed protein 4 (PATE4)

ACP24457

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP24457 Target NamePATE4
Target SynonymsFLJ41047; PATE-B; PATE-like protein B; Pate4; PATE4_HUMAN; Prostate and testis expressed 4; Prostate and testis expressed protein 4; Prostate and testis expression BFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range23-98
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP0C8F1
Background Information
  • Uniprot Id

    P0C8F1

  • Target Species

    Human

  • Target Name

    PATE4

  • Target Full Name

    Prostate and testis expressed protein 4

  • Target Function

    May modulate the function of nicotinic acetylcholine receptors. May enhance sperm motility.

  • Target Subcellular Location

    Secreted. Cytoplasmic vesicle, secretory vesicle, acrosome.

  • Target Protein Families

    PATE family

  • Target Tissue Specificity

    Specifically expressed in prostate, testis and spinal cord. Present in the acrosomal region of sperm cells. Present in apical epithelial cells of prostatic duct.

  • Target Synonyms

    FLJ41047; PATE-B; PATE-like protein B; Pate4; PATE4_HUMAN; Prostate and testis expressed 4; Prostate and testis expressed protein 4; Prostate and testis expression B

Inquire Recombinant Human Prostate and testis expressed protein 4 (PATE4) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification